Intravenous thrombolytic therapy for acute ischemic stroke

New England Journal of Medicine

Volumn 365, Issue 10, 2011, Pages 964-967

  Cohen, José E ^a   Leker, Ronen R ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ARTERY DIAMETER; BRAIN ISCHEMIA; DRUG APPROVAL; DRUG EFFICACY; ENDOVASCULAR SURGERY; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MEDICAL DECISION MAKING; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; TREATMENT OUTCOME;

EID: 80052562492     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1108289     Document Type: Letter

References (5)

1. Wechsler L.R. Intravenous thrombolytic therapy for acute ischemic stroke. N Engl J Med 2011;364:2138-2146
2. Cohen J.E., Itshayek E., Moskovici S., et al. State-of-the-art reperfusion strategies for acute ischemic stroke. J Clin Neurosci 2011;18:319-323
3. Adams H.P. Jr, Davis P.H., Leira E.C., et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126-131 (Pubitemid 29329660)
4. Saqqur M., Tsivgoulis G., Molina C.A., et al. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: A multicenter study. Neurology 2008;71:1304-1312
5. Rubiera M., Ribo M., Pagola J., et al. Bridging intravenous-intra- arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: A case-control study. Stroke 2011;42:993-997